Cathodal tDCS
Cathodal tDCS is a medical device with 11 clinical trials. Currently 1 active trials ongoing. Historical success rate of 88.9%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
88.9%
8 of 9 finished
11.1%
1 ended early
1
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Transcranial Direct Current Stimulation and Modulation of Affect and Pain
TDCs to Treat Drug-resistant Epilepsy
Improving Motor Stroke Recovery Using Patient-tailored Non-invasive Brain Stimulation
Modulation of Motor Cortex Excitability by TMS and tDCS (MAGS1)
tDCS on Motor Rehabiliation of Post Stroke Patients
Clinical Trials (11)
Transcranial Direct Current Stimulation and Modulation of Affect and Pain
TDCs to Treat Drug-resistant Epilepsy
Improving Motor Stroke Recovery Using Patient-tailored Non-invasive Brain Stimulation
Modulation of Motor Cortex Excitability by TMS and tDCS (MAGS1)
tDCS on Motor Rehabiliation of Post Stroke Patients
Effects of Transcranial Direct Current Stimulation Over the Left VLPFC on Cognitive Reappraisal
Effects of Transcranial Direct Current Stimulation on Pain Perception
Computerised Assessment of Visual Neglect Symptoms in Peripersonal Space
Randomized Trial of Transcranial Theta-burst Stimulation and Transcranial Direct Current Stimulation
Impact of tDCS on Cerebral Autoregulation
Improvement of Language Disturbances After Stroke by Intensive Training and Electrical Brain Stimulation
All 11 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 11